Conducted by: International Society of Hypertension – MENA Region
Estimated Time: 10–12 minutes | Anonymous and Confidential
1. Country of Practice Select your country
2. City / Province (Optional)
3. Type of Institution Public primary carePublic hospitalPrivate clinicAcademic hospitalMilitary hospitalOther
4. Your Role (Select all that apply) Cardiologist Internist Nephrologist Family Medicine / GP Endocrinologist Emergency Physician Pharmacist Nurse / Educator Policy Expert Other
5. Years of Experience Less than 5 5–10 11–20 More than 20
6. Number of hypertensive patients seen monthly <20 20–50 51–100 >100
7. Estimated hypertension prevalence by age group
<30 years
<5% 5–10% >10%
30–44 years
<10% 10–25% >25%
45–59 years
<25% 25–50% >50%
60–74 years
<50% 50–75% >75%
75+ years
8. Gender distribution among hypertensive patients Mostly male Mostly female Roughly equal
9. Comorbidities commonly seen with hypertension Diabetes Obesity Chronic Kidney Disease (CKD) Cardiovascular Disease Pregnancy-related hypertension None
10. Percentage of newly diagnosed patients <25% 25–50% >50%
11. Types of hypertension encountered White coat hypertension Masked hypertension Resistant hypertension
12. Do you manage hypertensive pregnant patients? Yes, directly Yes, with obstetrician No
13. Types of pregnancy-related hypertension encountered Gestational hypertension Chronic hypertension Preeclampsia Eclampsia
14. Do you screen all pregnant women for hypertension? Yes No
15. When is antihypertensive medication typically started during pregnancy? 140/90 mmHg 150/100 mmHg 160/110 mmHg Not standardized
16. Is postpartum hypertension follow-up routine in your practice? Yes – formally Yes – informally No
17. Would a regionally endorsed postpartum follow-up model be helpful? Yes No Not sure
18. Do you adjust drug timing/doses for fasting patients? Yes No Sometimes
19. Do you see more complications during Ramadan? Yes – e.g., hypertensive crises, dehydration No Not sure
20. Do you educate patients on BP monitoring during Ramadan? Yes No
21. Main challenge in managing hypertension during Ramadan
22. Most common method to measure BP Manual (mercury or aneroid) Automatic device Home BP monitoring 24-hour ambulatory BP monitoring
23. Are BP devices in your clinic validated? Yes No Not sure
24. How is hypertension diagnosis confirmed? Multiple clinic readings Home/ABPM confirmation One-time reading
25. BP threshold used to diagnose hypertension ≥140/90 mmHg ≥130/80 mmHg Other
26. Do you use cardiovascular risk scoring tools? Yes No
27. Do you assess kidney function for HTN patients? Yes No
28. Do you perform echocardiography in newly diagnosed cases? Always Sometimes Rarely Not available
29. Top 3 medication classes used (select up to 3) ARBs ACE inhibitors Calcium channel blockers Diuretics Beta blockers Fixed-dose combinations Other
30. Do you initiate with combination therapy? Yes Only in moderate/severe cases No
31. First follow-up after starting treatment is usually scheduled Within 1 month 1–3 months After 3 months
32. Routine follow-up frequency for stable hypertensive patients Every 1–3 months Every 6 months Yearly or less
33. Who is involved in follow-up? Physician Nurse Pharmacist None
34. Are pharmacists involved in medication review or adherence support? Yes – formally Occasionally No
35. Top barriers to BP control in your practice (select up to 3) Medication cost Poor adherence Health literacy Short consultations Cultural factors Limited validated devices Other
36. How do most patients pay for treatment? Government-funded Insurance (public/private) Out-of-pocket
37. Do you have any suggestions to improve hypertension care in your country or region?
